PDCD4 and lung cancer: In LLC lung cancer model, miR-21a from LLC-Exosomes are revealed to increase both the autocrine production of IL-6 and phosphorylation levels of STAT3 by targeting Programmed cell death 4(PDCD4), thereby preventing the activation of cytotoxic CD8+T cells and enhancing the proliferation and activity of MDSCs (76).